The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell(S) | 35K | $12.68 | $438K |
| Jun 21, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 67K | — | — |
| Jun 21, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 67K | — | $0 |
| Jun 4, 2026 | Anderson Thomas | Director | Grant(A) | 30K | — | $0 |
| Jun 4, 2026 | Watton Corey Michael | Director | Grant(A) | 30K | — | $0 |
| Jun 4, 2026 | Calder Douglas W | Director | Grant(A) | 30K | — | $0 |
| Jun 4, 2026 | Favorito Tamara A | Director | Grant(A) | 30K | — | $0 |
| Jun 4, 2026 | Secor Alicia | Director | Grant(A) | 30K | — | $0 |
| Jun 4, 2026 | Shih Alvin | Director | Grant(A) | 30K | — | $0 |
| May 28, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Grant(A) | 20K | — | $0 |
| May 28, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Grant(A) | 40K | — | $0 |
| May 11, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell(S) | 2K | $11.30 | $20K |
| Mar 24, 2026 | Bode John B | Director | Option exercise(M) | 39K | $4.97 | $195K |
| Mar 24, 2026 | Bode John B | Director | Option exercise(M) | 39K | $4.89 | $192K |
| Mar 24, 2026 | Bode John B | Director | Option exercise(M) | 39K | — | $0 |
| Mar 24, 2026 | Bode John B | Director | Option exercise(M) | 39K | — | $0 |
| Mar 18, 2026 | Renz Justin A | CFO | Grant(A) | 300K | — | $0 |
| Feb 9, 2026 | McFarlane Neil F. | President and CEO, Director | Sell(S) | 15K | $8.56 | $125K |
| Feb 7, 2026 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 38K | — | — |
| Feb 7, 2026 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 38K | — | $0 |
| Feb 3, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell(S) | 3K | $9.18 | $28K |
| Feb 3, 2026 | Schafer Joshua | CCO | Sell(S) | 11K | $9.19 | $96K |
| Feb 2, 2026 | McFarlane Neil F. | President and CEO, Director | Sell(S) | 91K | $9.38 | $854K |
| Jan 31, 2026 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 233K | — | — |
| Jan 31, 2026 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 233K | — | $0 |
| Jan 31, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 12K | — | — |
| Jan 31, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 12K | — | $0 |
| Jan 31, 2026 | Schafer Joshua | CCO | Option exercise(M) | 35K | — | — |
| Jan 31, 2026 | Schafer Joshua | CCO | Option exercise(M) | 35K | — | $0 |
| Jan 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell(S) | 2K | $8.82 | $15K |
| Jan 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 6K | — | — |
| Jan 30, 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 6K | — | $0 |
| Jan 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Sell(S) | 4K | $8.83 | $36K |
| Jan 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 11K | — | — |
| Jan 30, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 11K | — | $0 |
| Jan 30, 2026 | Quartel Adrian W | Chief Medical Officer | Sell(S) | 5K | $8.83 | $40K |
| Jan 30, 2026 | Quartel Adrian W | Chief Medical Officer | Option exercise(M) | 11K | — | — |
| Jan 30, 2026 | Quartel Adrian W | Chief Medical Officer | Option exercise(M) | 11K | — | $0 |
| Jan 30, 2026 | Schafer Joshua | CCO | Option exercise(M) | 11K | — | — |
| Jan 30, 2026 | Schafer Joshua | CCO | Sell(S) | 3K | $8.83 | $30K |
| Jan 30, 2026 | Schafer Joshua | CCO | Option exercise(M) | 11K | — | $0 |
| Jan 29, 2026 | McFarlane Neil F. | President and CEO, Director | Grant(A) | 125K | — | $0 |
| Jan 29, 2026 | McFarlane Neil F. | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Jan 29, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Grant(A) | 38K | — | $0 |
| Jan 29, 2026 | Thompson Rahsaan | Chief Legal & Compliance | Grant(A) | 75K | — | $0 |
| Jan 29, 2026 | Quartel Adrian W | Chief Medical Officer | Grant(A) | 38K | — | $0 |
| Jan 29, 2026 | Quartel Adrian W | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Jan 29, 2026 | Schafer Joshua | CCO | Grant(A) | 38K | — | $0 |
| Jan 29, 2026 | Schafer Joshua | CCO | Grant(A) | 75K | — | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Insider | Tax withholding(F) | 49K | $8.96 | $435K |
| Dec 31, 2025 | Clifton R. LaDuane | Insider | Option exercise(M) | 141K | — | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Insider | Option exercise(M) | 87K | — | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Insider | Option exercise(M) | 34K | — | $0 |
| Dec 31, 2025 | Clifton R. LaDuane | Insider | Option exercise(M) | 20K | — | $0 |
| Dec 2, 2025 | Secor Alicia | Director | Grant(A) | 45K | — | $0 |
| Oct 10, 2025 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 50K | — | — |
| Oct 10, 2025 | McFarlane Neil F. | President and CEO, Director | Sell(S) | 20K | $10.82 | $211K |
| Oct 10, 2025 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 50K | — | $0 |
| Sep 12, 2025 | Favorito Tamara A | Director | Buy(P) | 3K | $7.79 | $25K |
| Sep 12, 2025 | Shih Alvin | Director | Buy(P) | 20K | $7.89 | $158K |
| Aug 19, 2025 | Bode John B | Director | Buy(P) | 5K | $9.17 | $46K |
| Jun 26, 2025 | Thompson Rahsaan | Chief Legal & Compliance | Sell(S) | 24K | $9.21 | $221K |
| Jun 21, 2025 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 67K | — | — |
| Jun 21, 2025 | Thompson Rahsaan | Chief Legal & Compliance | Option exercise(M) | 67K | — | $0 |
| May 29, 2025 | Anderson Thomas | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Bode John B | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Watton Corey Michael | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Favorito Tamara A | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Calder Douglas W | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Dixon Wendy L | Director | Grant(A) | 30K | — | $0 |
| May 29, 2025 | Shih Alvin | Director | Grant(A) | 30K | — | $0 |
| Mar 28, 2025 | Watton Corey Michael | Director | Buy(P) | 300 | $7.84 | $2K |
| Mar 19, 2025 | Bode John B | Director | Buy(P) | 10K | $7.96 | $80K |
| Feb 14, 2025 | McFarlane Neil F. | President and CEO, Director | Sell(S) | 31K | $8.05 | $246K |
| Feb 13, 2025 | McFarlane Neil F. | President and CEO, Director | Sell(S) | 61K | $7.86 | $482K |
| Feb 13, 2025 | Clifton R. LaDuane | CFO & Treasurer | Sell(S) | 11K | $7.86 | $86K |
| Feb 13, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | Sell(S) | 11K | $7.86 | $83K |
| Feb 13, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Sell(S) | 3K | $7.86 | $24K |
| Feb 7, 2025 | McFarlane Neil F. | President and CEO, Director | Grant(A) | 113K | — | $0 |
| Feb 7, 2025 | McFarlane Neil F. | President and CEO, Director | Grant(A) | 225K | — | $0 |
| Jan 31, 2025 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 233K | — | — |
| Jan 31, 2025 | McFarlane Neil F. | President and CEO, Director | Option exercise(M) | 233K | — | $0 |
| Jan 31, 2025 | Clifton R. LaDuane | CFO & Treasurer | Option exercise(M) | 43K | — | — |
| Jan 31, 2025 | Clifton R. LaDuane | CFO & Treasurer | Option exercise(M) | 43K | — | $0 |
| Jan 31, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | Option exercise(M) | 35K | — | — |
| Jan 31, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | Option exercise(M) | 35K | — | $0 |
| Jan 31, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 12K | — | — |
| Jan 31, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Option exercise(M) | 12K | — | $0 |
| Jan 30, 2025 | Clifton R. LaDuane | CFO & Treasurer | Grant(A) | 68K | — | $0 |
| Jan 30, 2025 | Clifton R. LaDuane | CFO & Treasurer | Grant(A) | 34K | — | $0 |
| Jan 30, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | Grant(A) | 68K | — | $0 |
| Jan 30, 2025 | Schafer Joshua | CCO & EVP, Bus. Development | Grant(A) | 34K | — | $0 |
| Jan 30, 2025 | Thompson Rahsaan | Chief Legal & Compliance | Grant(A) | 34K | — | $0 |
| Jan 30, 2025 | Thompson Rahsaan | Chief Legal & Compliance | Grant(A) | 68K | — | $0 |
| Jan 30, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Grant(A) | 38K | — | $0 |
| Jan 30, 2025 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | Grant(A) | 19K | — | $0 |
| Jan 30, 2025 | Quartel Adrian W | Chief Medical Officer | Grant(A) | 68K | — | $0 |
| Jan 30, 2025 | Quartel Adrian W | Chief Medical Officer | Grant(A) | 34K | — | $0 |
| Oct 11, 2024 | Watton Corey Michael | Director | Buy(P) | 500 | $7.92 | $4K |
| Jul 17, 2024 | Clifton R. LaDuane | CFO & Treasurer | Buy(P) | 2K | $6.77 | $14K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).